Danielle Zerr

Adjunct Professor, Epidemiology
Professor, Pediatrics



MD Temple University, 1993
MPH Epidemiology, University of Washington, 1997
BA Biology, Brandeis University,



University of Washington Medical Center
Box 359300
Pediatrics, Division of Infectious Disease
Children's Hospital & Medical Ctr., Box 359300/MA.7.226
View Website »


Interim Division Chief and Professor of Pediatric Infectious Diseases, Affiliate Investigator at the Fred Hutchinson Cancer Research Center, and the Medical Director of Infection Prevention at Seattle Children’s Hospital

Research Interests

Dr. Zerr’s research interests lie in elucidating the epidemiology of healthcare-associated infectious diseases in children and immunocompromised hosts. A major area of focus is describing the natural history of human herpesvirus 6 and the clinical impact of viral reactivation in hematopoietic cell transplantation recipients. A second area of focus is describing the epidemiology of extended-spectrum cephalosporin-resistant Enterobacteriaceae in children and exploring strategies aimed at preventing and treating colonization and infection due to these organisms. She has successfully funded her research program since completing her training. Current grants support two projects: 1) a multicenter study describing the molecular epidemiology of antibiotic resistant Enterobacteriaceae in children, and 2) a randomized controlled trial of chlorhexidine gluconate bathing in children with cancer to determine whether the intervention reduces the incidence of central line associated bloodstream infections and acquisition of multi-drug resistant

Recent Publications (PubMed)

Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative.
(2022 May 2)
JAMA Pediatr
Woods-Hill CZ, Colantuoni EA, Koontz DW, Voskertchian A, Xie A, Thurm C, Miller MR, Fackler JC, Milstone AM, Bright STAR Authorship Group., Agulnik A, Albert JE, Auth MJ, Bradley E, Clayton JA, Coffin SE, Dallefeld S, Ezetendu CP, Fainberg NA, Flaherty BF, Foster CB, Hauger SB, Hong SJ, Hysmith ND, Kirby AL, Kociolek LK, Larsen GY, Lin JC, Linam WM, Newland JG, Nolt D, Priebe GP, Sandora TJ, Schwenk HT, Smith CM, Steffen KM, Tadphale SD, Toltzis P, Wolf J, Zerr DM

Higher Antibody Concentrations in U.S. Health Care Workers Associated with Greater Reactogenicity Post-Vaccination.
(2022 Apr 13)
Vaccines (Basel) 10(4):
Dickerson JA, Englund JA, Wang X, Brown JC, Zerr DM, Strelitz B, Klein EJ

NGSocomial Infections: High-Resolution Views of Hospital-Acquired Infections Through Genomic Epidemiology.
(2021 Dec 24)
J Pediatric Infect Dis Soc 10(Supplement_4): S88-S95
Greninger AL, Zerr DM

The Health Equity Impact Assessment: A Case Study in COVID-19 Visitor Policy.
(2021 Nov 4)
Hosp Pediatr
Olszewski AE, Adiele A, Patneaude A, Zerr DM, Kett JC

Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.
(2021 Sep 23)
J Pediatric Infect Dis Soc 10(8): 864-871
Fisher BT, Westling T, Boge CLK, Zaoutis TE, Dvorak CC, Nieder M, Zerr DM, Wingard JR, Villaluna D, Esbenshade AJ, Alexander S, Gunn S, Wheat LJ, Sung L

Show complete publication list

In the News

No news articles at this time.